[Apologies if you receive multiple copies of this message.]

Call for Papers
Special Issue: "Knowledge Engineering Methods and Applications in 
Pharmacovigilance"
BioMed Research International, http://www.hindawi.com/journals/bmri/

Drug safety is an important priority worldwide. Given the necessity to identify 
and track safety risks accurately and timely, the concurrent exploration of 
various types of data is necessary. Especially in postmarketing settings, these 
data span from spontaneous reports, electronic health records, the scientific 
literature, and even social media. The availability of this data deluge 
dictates the need to introduce high-throughput computational methods that will 
enable efficient knowledge extraction and management, compensating the 
underlying heterogeneity and complexity. Beyond discovery, knowledge 
representation, exploitation, and management are necessary for effective drug 
monitoring and surveillance. Knowledge engineering is the discipline that 
elaborates on the theories, methods, and tools for developing 
knowledge-intensive applications, and can largely contribute in the realization 
of the above objectives. Recently, and especially with the maturation of 
semantic web technologies and standards, various interesting applications and 
paradigms of knowledge engineering have been presented targeting the domain of 
pharmacovigilance.

Contributions to this special issue, either in the form of original research or 
in the form of review articles, may cover various aspects of knowledge 
engineering methods and applications in pharmacovigilance, illustrating the 
wide spectrum of potential in the domain. Major emphasis will be given to 
papers that illustrate the added value of knowledge engineering in the 
pharmacovigilance with scientific and tangible evidence.

Potential topics include, but are not limited to:
- Ontologies and knowledge bases targeting the domain of pharmacovigilance
- Semantic web and linked data applications and tools for pharmacovigilance
- Semantically-enriched big data analytics for drug safety risk monitoring and 
surveillance
- Knowledge-based systems for adverse drug event detection and prevention
- Natural language processing techniques driven by semantic technologies (e.g., 
applied in the literature and social media) in the domain of drug safety
- Integrated, knowledge-intensive platforms for drug safety
- Successful cases of applying knowledge engineering approaches in drug safety 
applications
- Early discovery of unknown adverse drug reactions and drug interactions

Authors can submit their manuscripts via the Manuscript Tracking System 
athttp://mts.hindawi.com/submit/journals/bmri/pharmacology/kema/.

Manuscript Due: Friday, 12 June 2015
First Round of Reviews: Friday, 4 September 2015
Publication Date: Friday, 30 October 2015

Lead Guest Editor:
    Marie-Christine Jaulent, INSERM, Paris, France

Guest Editors:
    Guoqian Jiang, Mayo Clinic, Rochester, USA
    Vassilis Koutkias, Centre for Research & Technology Hellas, Thessaloniki, 
Greece
    Hans-Ulrich Prokosch, University of Erlangen-Nuremberg, Erlangen, Germany

CFP Online:
    http://www.hindawi.com/journals/bmri/si/706947/cfp/
    http://downloads.hindawi.com/journals/bmri/si/706947.pdf

Guoqian Jiang, M.D., Ph.D.
===============================================================
Associate Professor of Biomedical Informatics
Associate Consultant in Department of Health Sciences Research,
Division of Biomedical Statistics & Informatics,
Mayo Clinic College of Medicine
200 First Street, SW,
Rochester, MN, 55905
Tel: 1-507-266-1327
Fax: 1-507-284-1516
Email: jiang.guoq...@mayo.edu<mailto:jiang.guoq...@mayo.edu>
=================================================================

Reply via email to